125 related articles for article (PubMed ID: 9285040)
1. Inhibition instead of enhancement of lipid peroxidation by pretreatment with the carcinogenic peroxisome proliferator nafenopin in rat liver exposed to a high single dose of corn oil.
Huber WW; Grasl-Kraupp B; Stekel H; Gschwentner C; Lang H; Schulte-Hermann R
Arch Toxicol; 1997; 71(9):575-81. PubMed ID: 9285040
[TBL] [Abstract][Full Text] [Related]
2. Induction of peroxisomal acyl CoA oxidase activity and lipid peroxidation in primary rat hepatocyte cultures.
Tomaszewski KE; Heindel SW; Jenkins WL; Melnick RL
Toxicology; 1990 Dec; 65(1-2):49-60. PubMed ID: 2274969
[TBL] [Abstract][Full Text] [Related]
3. Potent peroxisome proliferators inhibit beta-oxidation in the isolated perfused rat liver.
Bojes HK; Thurman RG
Toxicol Appl Pharmacol; 1996 Oct; 140(2):322-7. PubMed ID: 8887448
[TBL] [Abstract][Full Text] [Related]
4. Hepatic oxidative stress and related defenses during treatment of mice with acetylsalicylic acid and other peroxisome proliferators.
Cai Y; Appelkvist EL; DePierre JW
J Biochem Toxicol; 1995 Apr; 10(2):87-94. PubMed ID: 7562957
[TBL] [Abstract][Full Text] [Related]
5. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
Conway JG; Neptun DA; Garvey LK; Popp JA
Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
[TBL] [Abstract][Full Text] [Related]
6. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
James NH; Roberts RA
Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Just W; Gibson G; Schulte-Hermann R
Carcinogenesis; 1993 May; 14(5):1007-12. PubMed ID: 8099311
[TBL] [Abstract][Full Text] [Related]
8. Role of oxidative stress in age dependent hepatocarcinogenesis by the peroxisome proliferator nafenopin in the rat.
Huber W; Kraupp-Grasl B; Esterbauer H; Schulte-Hermann R
Cancer Res; 1991 Apr; 51(7):1789-92. PubMed ID: 2004363
[TBL] [Abstract][Full Text] [Related]
9. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
[TBL] [Abstract][Full Text] [Related]
10. Reduced expression of mature TGF beta 1 correlates with the suppression of rat hepatocyte apoptosis by the peroxisome proliferator, nafenopin.
Strange J; Roberts RA
Mutat Res; 1996 Nov; 372(1):107-13. PubMed ID: 9003537
[TBL] [Abstract][Full Text] [Related]
11. Nafenopin-induced peroxisome proliferation in vitamin A deficient rats.
Lawrence JW; Foxworthy PS; Perry DN; Jensen CB; Giera DD; Meador VP; Eacho PI
Biochem Pharmacol; 1995 Mar; 49(7):915-9. PubMed ID: 7741763
[TBL] [Abstract][Full Text] [Related]
12. Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset.
Lake BG; Evans JG; Gray TJ; Körösi SA; North CJ
Toxicol Appl Pharmacol; 1989 Jun; 99(1):148-60. PubMed ID: 2499080
[TBL] [Abstract][Full Text] [Related]
13. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Timmermann-Trosiener I; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2435-7. PubMed ID: 8242878
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator nafenopin potentiated cytotoxicity and genotoxicity of cyclophosphamide in the liver and bone marrow cells.
Voskoboinik I; Drew R; Ahokas JT
Chem Biol Interact; 1997 Jul; 105(2):81-97. PubMed ID: 9251722
[TBL] [Abstract][Full Text] [Related]
15. Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats.
Lake BG; Gray TJ; Körösi SA; Walters DG
Toxicol Lett; 1989 Feb; 45(2-3):221-9. PubMed ID: 2919403
[TBL] [Abstract][Full Text] [Related]
16. Effects of a peroxisome proliferator on beta-oxidation and overall energy balance in obese (fa/fa) rats.
Assimacopoulos-Jeannet F; Moinat M; Muzzin P; Colomb C; Jeanrenaud B; Girardier L; Giacobino JP; Seydoux J
Am J Physiol; 1991 Feb; 260(2 Pt 2):R278-83. PubMed ID: 1996714
[TBL] [Abstract][Full Text] [Related]
17. An overview of peroxisome proliferator-induced hepatocarcinogenesis.
Rao MS; Reddy JK
Environ Health Perspect; 1991 Jun; 93():205-9. PubMed ID: 1685443
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferators activate Kupffer cells in vivo.
Bojes HK; Thurman RG
Cancer Res; 1996 Jan; 56(1):1-4. PubMed ID: 8548746
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of nafenopin on hepatic peroxisome proliferation and replicative DNA synthesis in the rat and Syrian hamster.
Price RJ; Evans JG; Lake BG
Food Chem Toxicol; 1992 Nov; 30(11):937-44. PubMed ID: 1473786
[TBL] [Abstract][Full Text] [Related]
20. Induction of acyl-CoA oxidase and cytochrome P450IVA1 RNA in rat primary hepatocyte culture by peroxisome proliferators.
Bell DR; Elcombe CR
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):249-53. PubMed ID: 1720616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]